The ArthroFree™ System is available for sale. Now FDA market cleared. Contact us at [email protected] to learn more.

News

Lazurite’s ArthroFree™ Wireless Camera System for Minimally Invasive Surgery Receives FDA Market Clearance

by
March 24, 2022

CLEVELAND–(BUSINESS WIRE)–Lazurite today announced that its ArthroFree™ System is now the first and only wireless camera system for minimally invasive surgery to receive U.S. Food and Drug Administration (FDA) market clearance.

The ArthroFree™ System incorporates the company’s proprietary low-heat, high-intensity Meridiem™ light technology along with advanced camera, battery, and wireless transmission technologies. It is designed to deliver improved operating room productivity, patient safety, and economic value through cost-savings, energy efficiency, and reduced setup/breakdown times. The modular system also is designed to be drop-in compatible with patient data consoles, surgical displays and endoscopes found in minimally invasive operating rooms.

Visit the Lazurite CONTACT PAGE to request a demonstration/trial use or to purchase the ArthroFree™ System, which has received notable interest and accolades from prominent surgeons.

“I’ve had the opportunity to use the ArthroFree camera in the laboratory, and I’m absolutely amazed at the quality of the picture and the way the device feels in my hands,” said Mark Schickendantz, M.D., director of the Center for Sports Health at the Cleveland Clinic and since 1992 team physician for the Cleveland Guardians baseball team. “What’s incredible is to be able to use an arthroscope that doesn’t have the cumbersome cables. That is just absolutely incredible.”

“With ArthroFree, you have excellent quality images and simultaneously you have a clean, streamlined, uncluttered surgical field. It’s all built into the camera. When you pick it up and pop in the battery, it’s on. In a few years, I think, this is going to be the standard,” said University Hospitals Health System trauma surgeon Jeffrey Ustin, M.D.

“The ArthroFree™ System provides freedom of movement we’ve never had before,” saidLaith Jazrawi, M.D., Chief of Sports Medicine at NYU Langone Orthopedic Hospital. “You don’t have to move cables around. The camera is lightweight and easy to handle. I can’t imagine a surgeon who wouldn’t want this.”

Eugene Malinskiy, Chief Executive Officer and cofounder of Lazurite, emphasized the company’s commitment to creating high value innovation in partnership with the medical community. “The idea for what is now the FDA-cleared ArthroFree System was born from the very real need to create a safer, more efficient operating room for the benefit of everyone involved—from patients to surgeons to OR teams to clinics and hospitals.”

Malinskiy and his team believe “that this truly is the beginning of the operating room of the future. The entire endoscopic market will benefit from our minimally invasive surgical equipment advancement going forward.”

Mark Froimson, M.D., Chair of the Board of Lazurite elaborated, “We are proud to have achieved this major milestone on our way to bringing operating rooms across the country into the wireless age. In the coming year, we will be introducing the ArthroFree System to thousands of healthcare professionals at conferences, in demos, through distributors and group purchasing channels, and through partnerships with leading medical centers.”

Physicians and other healthcare professionals are encouraged to experience pre-production demo models of the ArthroFree System at a range of upcoming medical conferences this year:

  • American Academy of Orthopaedic Surgeons (AAOS), March 22-26 in Chicago (Booth 2305)
  • Ambulatory Surgery Center Association (ASCA), April 27-30 in Dallas (Booth 424)
  • Arthroscopy Association of North America (AANA) May 19-21 in San Francisco
  • American Orthopaedic Society for Sports Medicine (AOSSM), July 13-18 in Colorado Springs
  • American College of Surgeons (ACS), October 16-18 in San Diego

About Lazurite

Lazurite (formerly Indago) is a medical device startup company backed by private capital. The company has raised more than $18 million to date from institutional investors, family offices, and more than 50 physician champions. The Cleveland-based company (est. 2015) designs devices to set new operating-room standards for efficiency and patient safety. Lazurite’s ArthroFree™ System is the first FDA-cleared, wireless camera system for minimally invasive surgery. The ArthroFree System enables surgical visualization in minimally invasive surgery without the camera and light wires implicated in patient infections, burns, and costly post-operative care. Lazurite’s current product pipeline includes devices that incorporate their patented camera technology and laser light technology. Lazurite’s technologies are protected by a comprehensive intellectual property portfolio encompassing the ArthroFree wireless surgical camera system and the novel Meridiem™ light source as well as other products currently in development. For more information, see: https://lazurite.co.

Forward Looking Statements

This press release includes “forward-looking statements.” Forward-looking statements can be identified by words such as: “anticipate,” “intend,” “plan,” “believe,” “project,” “estimate,” “expect,” “may,” “should,” “will,” “designed,” “milestone,” and similar references to future periods. Examples of forward-looking statements include, among others, statements we make regarding the expected impact of the ArthroFree System on the field of minimally invasive surgery and our future sales of the ArthroFree System. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations, and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy, and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks, and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

Lazurite™, ArthroFree™, and Meridiem™ are trademarks of Lazurite Holdings LLC.

Media Center

Visit https://www.lazurite.co/mediafor videos, logos, images, fact sheets, bios and more.

View the full release here: https://www.businesswire.com/news/home/20220324005350/en/

Contacts

For Lazurite:
Pat Gallagher
Patrick Gallagher PR & Marketing Communications
[email protected]
+1 (216) 233-7473
Lazurite: +1 (833) 214-2324
[email protected]